ITeos Therapeutics Newsroom

ITeos Therapeutics Analyst Ratings

BenzingaNov 15 07:36 ET

H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsNov 15 06:31 ET

Leerink Partners Maintains ITeos Therapeutics(ITOS.US) With Buy Rating

Moomoo NewsNov 14 03:33 ET

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsNov 13 06:36 ET

Strategic Catalysts and Financial Stability Underpin Buy Rating for ITeos Therapeutics

TipRanksNov 13 05:50 ET

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsSep 17 05:32 ET

ITeos Therapeutics Analyst Ratings

BenzingaSep 16 07:42 ET

Piper Sandler Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsSep 16 07:31 ET

ITeos Therapeutics (ITOS) Receives a Buy From Piper Sandler

TipRanksSep 16 06:59 ET

H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsSep 16 06:31 ET

Wedbush Raises Price Target on ITeos Therapeutics to $25 From $21, Keeps Outperform Rating

MT NewswiresSep 16 06:27 ET

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsSep 14 09:32 ET

Buy Rating Affirmed for ITeos Therapeutics Amid Promising Lung-201 Study Outcomes

TipRanksSep 14 08:58 ET

J.P. Morgan Sticks to Its Buy Rating for ITeos Therapeutics (ITOS)

TipRanksAug 13 08:34 ET

Wells Fargo Initiates ITeos Therapeutics(ITOS.US) With Buy Rating, Announces Target Price $31

Moomoo NewsAug 13 06:31 ET

ITeos Therapeutics Analyst Ratings

BenzingaAug 12 10:39 ET

Buy Rating Affirmed for ITeos Therapeutics on Strong Financials and Promising Pipeline Updates

TipRanksAug 9 07:18 ET

ITeos Therapeutics Analyst Ratings

BenzingaMay 13 07:16 ET

Analysts Offer Insights on Healthcare Companies: ITeos Therapeutics (ITOS), Rani Therapeutics Holdings (RANI) and Vor Biopharma (VOR)

TipRanksMar 21 07:36 ET

ITeos Therapeutics Analyst Ratings

BenzingaMar 12 09:11 ET